| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |